Price target upside
Rocket Pharmaceuticals Price Target: +141.6% vs Current Price
RCKT target gap is +141.6% from $3.66 to $8.84. As of 2026-08-27.
Direct answer
Rocket Pharmaceuticals's analyst target implies +141.6%.
The average target is $8.84 compared with a recorded current price of $3.66.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 27, 2026.
Get free Rocket Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.66
- Average price target
- $8.84
- High price target
- $15.00
- Low price target
- $3.00
- Low target gap
- -18%
- Target upside
- +141.6%
- High target gap
- +309.8%
- Target range width
- 327.9%
- Consensus rating
- Buy
- Analysts
- 11
- Evidence date
- August 27, 2026
- Valid through
- September 3, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does Rocket Pharmaceuticals's average target imply?
Rocket Pharmaceuticals's average target is $8.84 versus a recorded price of $3.66. The difference is +141.6%.
How far are Rocket Pharmaceuticals's low and high targets from the recorded price?
The low target implies -18%, while the high target implies +309.8%.
How many analysts are included in Rocket Pharmaceuticals's consensus?
The verified consensus includes 11 analysts.
How is Rocket Pharmaceuticals's target upside or downside calculated?
The average target of $8.84 is divided by the recorded price of $3.66, then one is subtracted to produce +141.6%. This does not guarantee a future return.
When was Rocket Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-08-27. The dataset is valid through 2026-09-03.